Published in Am J Clin Nutr on December 01, 1978
Effect of high-dose Ascorbic acid on vasopressor's requirement in septic shock. J Res Pharm Pract (2016) 0.89
Whole-body protein breakdown and 3-methylhistidine excretion during brief fasting, starvation, and intravenous repletion in man. Ann Surg (1985) 0.81
Calcium and phosphorus metabolism during total parenteral nutrition. Ann Surg (1983) 0.78
Shock and tissue injury induced by recombinant human cachectin. Science (1986) 16.24
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (1988) 13.42
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg (2000) 13.24
Impact of hospital volume on operative mortality for major cancer surgery. JAMA (1998) 11.05
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg (1993) 6.15
Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg (1995) 5.90
Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg (1998) 5.87
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol (1996) 5.40
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med (1996) 5.25
Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med (1988) 5.16
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med (1989) 4.66
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg (1996) 4.51
A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg (1995) 4.24
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med (1998) 4.18
Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet (1987) 4.18
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol (1996) 3.85
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A (1992) 3.61
An overview of mortality risk prediction in sepsis. Crit Care Med (1995) 3.37
Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet (1988) 3.30
Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg (2000) 3.06
Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res (1994) 2.98
Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91
The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer (1999) 2.90
Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res (2001) 2.80
The National Cancer Data Base report on pancreatic cancer. Cancer (1995) 2.77
Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol (1993) 2.71
Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut (2008) 2.69
Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg (1999) 2.65
Soft tissue sarcomas. Curr Probl Surg (1996) 2.62
Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer (1989) 2.57
The enigma of desmoid tumors. Ann Surg (1999) 2.57
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39
Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis (1997) 2.39
Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol (1999) 2.30
Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol (2000) 2.22
Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17
Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol (1997) 2.10
Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg (1999) 2.09
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest (1990) 2.08
Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg (1993) 2.07
Factors predictive of survival in ampullary carcinoma. Ann Surg (1998) 2.06
Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol (2001) 2.06
Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg (2000) 2.05
IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol (1991) 2.03
Drainage is unnecessary after elective liver resection. Am J Surg (1996) 2.03
Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer (1999) 2.03
Inflammatory cytokines and cell response in surgery. Surgery (2000) 2.02
Surgical management of intra-abdominal desmoid tumours. Br J Surg (2000) 2.01
Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest (1996) 1.99
Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg (1996) 1.97
The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97
Gallbladder cancer discovered during laparoscopic surgery. Potential for iatrogenic tumor dissemination. Arch Surg (1993) 1.94
Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol (1995) 1.94
Adult urological sarcoma. J Urol (1992) 1.94
Cachectin: a hormone that triggers acute shock and chronic cachexia. J Infect Dis (1988) 1.94
Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg (1992) 1.92
Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91
Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology (1991) 1.90
Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis (1996) 1.88
Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg (2000) 1.88
Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer (2001) 1.86
Radiation-associated sarcoma of bone and soft tissue. Arch Surg (1992) 1.84
Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol (2000) 1.83
Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J (1989) 1.82
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol (2004) 1.80
Effect of reresection in extremity soft tissue sarcoma. Ann Surg (2000) 1.80
Uncomplicated starvation versus cancer cachexia. Cancer Res (1977) 1.79
Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg (1989) 1.79
The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg (1991) 1.79
Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg (1991) 1.79
Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Cancer (2000) 1.78
Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol (1997) 1.77
Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol (1997) 1.75
Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol (1993) 1.73
A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg (1997) 1.69
Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68
Predictive value of benign percutaneous adrenal biopsies in oncology patients. Clin Radiol (2002) 1.68
Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology (1991) 1.68
The desmoid tumor. Not a benign disease. Arch Surg (1989) 1.66
Histopathologic changes seen in esophagectomy specimens from the high-risk region of Linxian, China: potential clues to an etiologic exposure? Hum Pathol (1998) 1.65
Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg (1991) 1.64
The role of the pathologist in the management of soft tissue sarcomas. World J Surg (1988) 1.64
Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J Infect Dis (1997) 1.63
An eleven-year experience with adrenocortical carcinoma. Surgery (1992) 1.62
Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg (1994) 1.61
Is gastric carcinoma different between Japan and the United States? Cancer (2000) 1.61
Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis. Arch Surg (1987) 1.59
Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest (1988) 1.59
Role of fine-needle aspiration biopsy and frozen section analysis in the surgical management of thyroid tumors. Ann Surg Oncol (2001) 1.58
Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol (1992) 1.58
Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism. Ann Surg (1992) 1.57
Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res (1990) 1.57
Primary gastrointestinal sarcomas: analysis of prognostic variables. Ann Surg Oncol (1995) 1.56